Plants and certain protists use cycloeucalenol cycloisomerase (EC 5.5.1.9) to convert pentacyclic cyclopropyl sterols to conventional tetracyclic sterols. We used a novel complementation strategy to clone a cycloeucalenol cycloisomerase cDNA. Expressing an Arabidopsis thaliana cycloartenol synthase cDNA in a yeast lanosterol synthase mutant provided a sterol auxotroph that could be genetically complemented with the isomerase. We transformed this yeast strain with an Arabidopsis yeast expression library and selected sterol prototrophs to obtain a strain that accumulated biosynthetic ergosterol. The novel phenotype was conferred by an Arabidopsis cDNA that potentially encodes a 36-kDa protein.
Plants and certain protists use cycloeucalenol cycloisomerase (EC 5.5.1.9) to convert pentacyclic cyclopropyl sterols to conventional tetracyclic sterols. We used a novel complementation strategy to clone a cycloeucalenol cycloisomerase cDNA. Expressing an Arabidopsis thaliana cycloartenol synthase cDNA in a yeast lanosterol synthase mutant provided a sterol auxotroph that could be genetically complemented with the isomerase. We transformed this yeast strain with an Arabidopsis yeast expression library and selected sterol prototrophs to obtain a strain that accumulated biosynthetic ergosterol. The novel phenotype was conferred by an Arabidopsis cDNA that potentially encodes a 36-kDa protein.
We expressed this cDNA (CPI1) in Escherichia coli and showed by gas chromatography-mass spectrometry that extracts from this strain isomerized cycloeucalenol to obtusifoliol in vitro. The cDNA will be useful for obtaining heterologously expressed protein for catalytic studies and elucidating the in vivo roles of cyclopropyl sterols.
Even distantly diverged organisms generally biosynthesize shared molecules by such similar routes that bacteria and yeast have been suitable systems for deducing much of human metabolism. Sterol biosynthesis provides an exception to this trend. Eukaryotes use two distinct pathways ( Fig. 1 ) to make structurally similar sterols (1) . Animals and fungi cyclize oxidosqualene to the tetracyclic ⌬ 8 -triterpene lanosterol (2), which they metabolize further to tetracyclic membrane sterols (3) (4) (5) . Plants cyclize instead to the pentacyclic cycloartenol (6, 7) and consequently must isomerize the cyclopropane ring to form ⌬ 8 tetracycles en route to tetracyclic sterols. Why plants use this two-enzyme route (8) rather than cyclizing directly to tetracyclic sterols using lanosterol synthase remains unknown.
Although the enzyme has not been purified to homogeneity, cycloeucalenol cycloisomerase (also known as cycloeucalenolobtusifoliol isomerase) activity has been observed directly in both dicots (9) and monocots (10) . In addition, the presence of an isomerase has been demonstrated indirectly in diverse plants (11) (12) (13) (14) and the protozoan Acanthamoeba polyphaga (15) by identifying cyclopropyl sterols after treatment with isomerase inhibitors. In D 2 O, the isomerase adds a deuterium to C-19 and abstracts hydrogen from C-8 (16, 17) . Neither ATP nor NADPH enhances activity (8) , and acidic ring opening seems the most likely mechanism. Because the nonenzymatic acid-catalyzed isomerization (18) requires severe conditions (10% H 2 SO 4 in refluxing isopropyl alcohol for 24 h), it is likely that the enzyme employs a metal or an unusually acidic amino acid residue to open the ring.
As a prelude to investigating its catalytic mechanism and biological function, we have cloned and heterologously expressed the Arabidopsis thaliana cDNA that encodes cycloeucalenol cycloisomerase.
EXPERIMENTAL PROCEDURES
Cloning the Cycloeucalenol Cycloisomerase cDNA-The A. thaliana CAS1 1 cDNA (19) cloned into the integrative yeast expression vector pRS305GAL (20) was used to transform the yeast lanosterol synthase mutant SMY8 (20) using lithium acetate (21) . The resultant yeast lanosterol synthase mutant expressing cycloartenol synthase (named SMY10, MATa pGAL-CAS1 erg7::HIS3 hem1::TRP1 ura3-52 trp1-⌬63 his3-⌬200 ade2 Gal ϩ ) was cultured using conditions previously described for SMY8 (20) . SMY10 was transformed with a yeast expression library (22) containing A. thaliana cDNAs. Transformants were selected on synthetic complete plates (23) lacking uracil and supplemented with ergosterol (20 g/ml), heme (13 g/ml), and Tween 80 (5 mg/ml). The transformants were replica-plated onto inducing media without sterol (1% yeast extract, 2% peptone, 2% galactose, 1.5% agar, and 13 g/ml heme) to select sterol prototrophs. TLC analysis of five sterol prototrophs showed that one strain contained a compound with chromatographic (1:1 hexane/ether, R f ϭ 0.41) and UV-absorbing characteristics consistent with those of ergosterol. A 1-liter culture (1% yeast extract, 2% peptone, 2% galactose, 13 g/ml heme) provided enough sterol to confirm the structure. The cells were recovered by centrifugation and subjected to Soxhlet extraction in ethanol for 6 h. After concentration in vacuo, the residue was partitioned between ethyl acetate and water, and the combined organic layers were dried over anhydrous magnesium sulfate and concentrated in vacuo. Silica gel chromatography (1:1 hexane/ether) provided 4.3 mg of an UV-active compound that comigrated with ergosterol on TLC (1:1 hexane/ether, R f ϭ 0.41), and subsequent 1 H NMR characterization indicated a conjugated diene. This preliminary structure determination suggested that the new gene encoded the isomerase, and the plasmid was consequently characterized. To cover the possibility that related genes will be found that target other cyclopropyl sterol substrates, we named the gene CPI1 (cyclopropyl sterol isomerase).
Plasmid Characterization-The sterol-independent strain was plated on synthetic complete medium containing 1 mg/ml 5-fluoroorotic acid to select against the plasmid-borne uracil biosynthetic gene (24) . The resultant plasmid-free strain again required ergosterol, showing that the plasmid encoded the novel enzymatic activity. The plasmid was * This work was supported in part by National Institutes of Health Grant AI41598 and the Robert A. Welch Foundation Grant C-1323. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. isolated from the yeast using glass bead lysis with phenol, chloroform, and SDS followed by ethanol precipitation (23) . DNA was further purified using Qiaex ion-exchange resin (Qiagen, Chatsworth, CA) and used to transform Escherichia coli strain DH5␣ by electroporation (23). The 1.2-kbp insert of the plasmid (named pML1) was excised with NotI and subcloned into pBluescript II KS(ϩ) (Stratagene, La Jolla, CA). Both insert strands were sequenced using vector-derived and internal primers.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank
Construction of Saccharomyces cerevisiae Strain MLY1-The S. cerevisiae lanosterol synthase mutant SMY8 (20) was used as an integration host for pML1.5, a LEU2-marked integrating plasmid encoding the putative A. thaliana isomerase under galactose-inducible control. The plasmid was constructed by inserting the PstI/SacII fragment of pML1 into pRS305GAL (20) cut with the same enzymes. The plasmid was linearized by digestion with BstEII and transformed into SMY8 using the lithium acetate method (21) . Transformants were selected on synthetic complete plates (23) lacking leucine and supplemented with ergosterol (20 mg/ml), heme (13 mg/ml), and Tween 80 (5 mg/ml). The resulting yeast strain was named MLY1.
MLY1 was subsequently transformed with pSM60.20, which was constructed by subcloning the A. thaliana CAS1 insert (21) into the centromeric yeast shuttle vector pRS316GAL (25) . Transformants were selected on synthetic complete plates lacking uracil and supplemented with ergosterol (20 mg/ml), heme (13 mg/ml), and Tween 80 (5 mg/ml). A 4.5-liter culture of the MLY1[60.20] yeast strain was grown in inducing medium (1% yeast extract, 2% peptone, 2% galactose, 13 mg/ml heme) to saturation at 30°C. Cells were harvested by centrifugation and subjected to saponification (10% w/v methanolic KOH at reflux for 1 h). The reaction was concentrated in vacuo and extracted three times with diethyl ether, and the combined organic extracts were dried over anhydrous magnesium sulfate. Column chromatography (1:1 hexane/ ether) of the collected organic material afforded nearly 8 mg of the putative ergosterol. High pressure liquid chromatography was employed to purify the UV-active compound (YMC Si column, 4.6 ϫ 250 mm, isocratic 80:20 hexane/t-butyl methyl ether, 1 ml/min, monitored at 204 nm) and yielded approximately 4 mg of the UV-active compound. 1 H and 13 C NMR characterization confirmed that the compound was ergosterol.
E. coli Expression and Enzymatic Assays-An expression construct made by subcloning the 1.2-kbp insert of pML1 into pET-15b (Novagen) was used to transform the E. coli expression host strain BL21(DE3)pLysS (Novagen). A 125-ml Erlenmeyer flask containing 25 ml of Luria broth (23) supplemented with 100 g/ml carbenicillin and 25 g/ml chloramphenicol was inoculated with 500 l of a saturated culture. After 1 h at 37°C, isopropyl ␤-D-thiogalactopyranoside was added to 1 mM to induce expression, and the culture was shaken for 5 h at 37°C. The cells were harvested by centrifugation and resuspended at 20% w/v in buffer (0.1 M Tris/HCl, 5 mM dithiothreitol, 4 mM MgCl 2 , 0.2% Tween 80 (v/v), pH 7.8). Cycloeucalenol was added from an ethanolic solution to 100 M, and the cells were lysed by 3 cycles of 10 s sonication and 5 min on ice. After incubating for 15 h at ambient temperature, cold ethanol (2 volumes) was added, and denatured protein and cellular debris were removed by centrifugation. The supernatant was reserved, and the pellet was re-extracted with 0.5 ml of ethanol. The combined ethanolic extracts were concentrated in vacuo, and the residue was partitioned between ether and water. The combined ethereal extracts were passed over a silica gel plug and concentrated to dryness. The sterols were silylated with 1:1 pyridine/bis(trimethylsilyl)trifluoroacetamide and analyzed by gas chromatography (Rtx-5, 30 m ϫ 0.25 mm inner diameter, 0.10-m df, 290°C detector and inlet, isothermal 280°C oven, helium carrier gas, 1-40 split). Areas corresponding to the obtusifoliol (11.49 min) and cycloeucalenol (12.97 min) tetramethylsilane ethers were integrated. The identities of the recovered starting material and product were confirmed by gas chromatography-mass spectrometry. A control reaction with the E. coli host carrying the empty vector did not open the cyclopropane ring, showing that the isomerase activity was encoded by the A. thaliana cDNA.
RESULTS AND DISCUSSION
Cycloeucalenol cycloisomerase is a membrane protein (26) , and although it has been partially purified from maize by differential and sucrose density gradient centrifugation (10), purifying protein to homogeneity (a prerequisite for peptide sequence-based cloning) has not been reported. Conventional complementation approaches were impossible because hosts such as yeast and bacteria lack the isomerase, precluding the generation of mutants for complementation. We therefore metabolically engineered a yeast strain that mimicked an isomerase mutant. Yeast cyclizes oxidosqualene directly to lanosterol, a tetracyclic sterol precursor (27) . Because the yeast lanosterol synthase mutant SMY8 (20) cannot make sterol, it requires ergosterol supplementation. SMY10 (an SMY8 derivative expressing A. thaliana cycloartenol synthase (19) from the integrated yeast expression vector pRS305GAL) converts biosynthetic oxidosqualene to cycloartenol. We found that SMY10 requires ergosterol, like other lanosterol synthase mutants producing endogenous cycloartenol (28) or grown on exogenous cycloartenol (29) . This is consistent with previous studies that showed low (30) (50) is alkylation followed by demethylation to cycloeucalenol, which is isomerized to obtusifoliol. Like those of yeast (51), plant sterol biosynthetic enzymes can have broad substrate specificities, and consequently sterol biosynthesis does not follow a strict order in plants.
To simplify the presentation of diverse animal, fungal, and plant sterols, the variable side chains are abbreviated as R.
sterol-independent. The major uncertainty with using SMY10 as a complementation host for this experiment was that 4,4-dimethyl cyclopropyl sterols such as cycloartenol are not measurably metabolized by higher plant isomerases (8, 9, 32) . For example, the bramble isomerase accepts cycloeucalenol and other 4-desmethyl sterols but has little activity on cycloartenol (9) . If cycloartenol were the only sterol accumulating in the SMY10 host, isomerase expression would not restore ergosterol prototrophy. Fortunately, yeast at least partially demethylates cycloartenol at the 4-position (29, 33) . The yeast demethylating enzymes Erg25, Erg26, and Erg27 (34 -36) that normally metabolize lanosterol apparently have sufficiently broad substrate specificity to accept its isomer cycloartenol. We reasoned that the isomerase would accept the resulting demethyl cyclopropyl sterols and convert them to tetracyclic ⌬ 8 sterols, which wild-type yeast enzymes would metabolize further to ergosterol (Fig. 2) . The likelihood of complementation would depend on whether this level of ergosterol production was sufficient to support life. Fortunately, yeast can use a variety of different compounds for bulk membrane sterol as long as a trace of ergosterol is present (37, 38) . For example, yeast lanosterol synthase mutants grow well on 5 mg/liter cycloartenol but only if supplemented with 0.5 mg/liter ergosterol (29) . These earlier findings suggested that a yeast lanosterol synthase mutant expressing cycloartenol synthase might gain a growth advantage upon obtaining an isomerase gene, and the success of our screen confirms this prediction.
The complementation host was constructed by transforming a lanosterol synthase mutant with a plasmid expressing the A. thaliana cycloartenol synthase under galactose control. The resulting strain was transformed with a yeast library (22) expressing A. thaliana cDNAs from a constitutive promoter, and sterol-independent strains were selected on sterol-free medium with galactose as a carbon source (to induce the cycloartenol synthase). One yeast strain became sterol-dependent when it lost its plasmid, suggesting that the plasmid facilitated sterol biosynthesis. Yeast that coexpresses the novel protein and cycloartenol synthase synthesize significant amounts of ergosterol in vivo, and the enzyme expressed in E. coli converts cycloeucalenol to obtusifoliol in vitro. The cDNA consequently encodes cycloeucalenol cycloisomerase, and we named the corresponding gene CPI1 (cyclopropyl sterol isomerase).
CPI1 encodes a predicted 36-kDa protein (Fig. 3) with a calculated isoelectric point of 7.3. Analysis with the SMART program (39) predicted four to seven transmembrane domains and a potential signal sequence, consistent with the observation that the isomerase is a membrane protein (26) . A BLAST search (40) of A. thaliana genomic DNA identified a 2.3-kbp sequence on P1 clone MXI22 (41) identical to CPI1 except for the presence of seven introns. Only a few of these splice sites were correctly predicted by exon identification programs, highlighting the continued importance of cDNA sequence information for transcript identification in genomic analysis. No close homologs are present in Arabidopsis genomic DNA sequenced to date (84% complete as of January, 2000), suggesting that CPI1 is a single copy gene in Arabidopsis.
CPI1 maps near the bottom of chromosome 5, just south of the molecular marker nga129 (42) . Cycloeucalenol cycloisomerase mutants have not been described, but recent technical advances allow the isolation of A. thaliana disruption mutants (43) when sequence information is available. cpi1 mutants would be useful for determining the biological function of cyclopropyl sterols. If cpi1 mutants are viable, they should have cyclopropyl membrane sterols instead of conventional tetracyclic ones. Tobacco calli selected for resistance to normally inhibitory concentrations of the isomerase inhibitor fenpropimorph contain up to 99% cyclopropyl sterols (44) , suggesting that cyclopropyl sterols can be effective membrane components. Because functional cyclopropyl brassinosteroids have not been described, cpi1 mutants might therefore be expected to be brassinosteroid-deficient dwarfs. No brassinosteroid biosynthetic mutants have been reported to map to the region of chromosome 5 that contains CPI1.
The A. thaliana CPI1 and CAS1 genes could be useful to make transgenic plants for determining why plants use the 
FIG. 2.
A functional ergosterol biosynthetic pathway encoded by yeast and plant genes. Wild-type yeast biosynthesizes oxidosqualene, which it cyclizes to the sterol precursor lanosterol. A yeast strain with lanosterol synthase replaced with cycloartenol synthase produces cycloartenol, which it partially metabolizes to various desmethyl cyclopropyl sterols (29) . The isomerase can convert these compounds to tetracyclic sterols that yeast enzymes metabolize to ergosterol. The are several possible side chain structures, which are abbreviated as R.
tandem pair rather than lanosterol synthase. Plants rapidly metabolize lanosterol to sterols (45) , so a transgenic plant expressing lanosterol synthase in place of cycloartenol synthase and the isomerase should be able to make conventional tetracyclic membrane sterols. However, it would lack cyclopropyl sterols completely and should have a discernible phenotype if these compounds have biological roles other than as precursors to tetracyclic sterols.
Comparing the CPI1 cDNA to other plant sequences revealed similar genes in corn (cDNAs with GenBank TM accession numbers AW065429, AI967279, AI947898, and AI586678), cotton (cDNA AW187278), rice (cDNA C97202 and genomic fragment AQ859984), and tomato (cDNAs AI773332, AI782398, AI780029 and genomic fragment AQ367965). No fungal or bacterial sequences, including the completely sequenced S. cerevisiae and E. coli genomes, show significant sequence identity to A. thaliana CPI1. Moreover, the nematode Caenorhabditis elegans, which lacks sterol biosynthesis altogether, also lacks a CPI1 homolog.
The yeast ergosterol biosynthetic pathway has been studied extensively, and all of the yeast sterol biosynthetic genes have been cloned (34, 35, 46) . Because fungi and plants share similar sterol biosynthetic pathways, sequence comparisons coupled with genomic sequencing efforts will soon uncover the A. thaliana and rice homologs of yeast sterol biosynthetic genes. The plant pathway requires four enzymatic activities absent in the yeast pathway that would not necessarily be accessible by homology-based approaches. cDNAs encoding three of these have already been described: cycloartenol synthase (19) , sterol ⌬ 7 -reductase (47), and a second sterol methyltransferase (48) . CPI1 is the last of these genes that lacks an obvious homolog in yeast sterol biosynthesis. It consequently may be relatively straightforward to clone the remaining plant sterol biosynthetic genes by homology to yeast genes.
Finally, the isomerase is a promising antiprotozoal drug target because parasitic amoebae such as Acanthamoeba (15) and Naegleria (49) use cycloeucalenol cycloisomerase, whereas humans and other vertebrates apparently do not. The cloned and expressed isomerase should greatly facilitate mechanistic studies of these enzymes and subsequent inhibitor design.
